TABLE 1.

Baseline demographic characteristics and previous malarial histories of subjects on tafenoquine and mefloquine for malaria prophylaxis

CharacteristicValue for subjects who received:
Tafenoquine (n = 492)Mefloquine (n = 162)
No. (%) of subjects
    Gender
        Male478 (97.2)154 (95.1)
        Female14 (2.8)8 (4.9)
    Age (yr)
        18-25286 (58.1)97 (59.9)
        26-35178 (36.2)48 (29.6)
        36-4527 (5.5)16 (9.9)
        46-551 (0.2)1 (0.6)
    Race
        White484 (98.4)160 (98.8)
        Aboriginal/Torres Strait Islander4 (0.8)1 (0.6)
        Other4 (0.8)1 (0.6)
    Previous history of malaria15 (3.0)4 (2.5)
    Having malaria attacks in 6 mo prior to deployment9 (1.8)1 (0.6)
Age
    Mean (SD)25.4 (5.3)26.0 (6.5)
    Range18-4718-51
Weight (kg)
    Mean (SD)80.9 (11.9)81.3 (12.2)
    Range50-13553-135
Height (cm)
    Mean (SD)177.8 (7.0)177.1 (6.7)
    Range155-198157-192